Short description
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Description
Tango Therapeutics operator of a biotechnology company created to discover novel drug targets and deliver the next generation of targeted therapies to people with cancer. The company's research leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2017
Exited on
August 11, 2021
Went public on
August 11, 2021
Stock symbol
TNGX
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu, Noway Youcantaccess, Absolutely Noaccess, Uh Ohhhh, Nopepepe, Blurry Noaccess, No Way, Noway Youcantaccess, Cannot Access, Noaccessforu, No Way, No Way, Noaccess, Noaccessforu, Cannot Access, Noaccess, Noway Youcantaccess, Noway Youcantaccess
Sign in for full access
Founders
Alan Ashworth, José Baselga, Timothy K. Lu